Health Tech Capitol | Propeller Health presents data on asthma and COPD at the European Respiratory Society International Congress
15968
post-template-default,single,single-post,postid-15968,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Propeller Health presents data on asthma and COPD at the European Respiratory Society International Congress

19 Sep Propeller Health presents data on asthma and COPD at the European Respiratory Society International Congress

Posted at 12:04h in Uncategorized by
0 Likes
MADISON, Wis., Sept. 19, 2017 /PRNewswire/ — Today, Propeller Health released the results from three new asthma and COPD studies presented last week at the European Respiratory Society International Congress (ERS) in Milan, Italy. The five-day event is the world’s largest respiratory health meeting.

The company shared interim results on the feasibility and clinical impact of a digital health intervention (Propeller) among a Medicare population with COPD. This study monitored 201 participants over a six-month period, and demonstrated a significant decrease in short-acting bronchodilator (SABA) use and an increase in symptom-free days.

In a second presentation, Propeller shared findings from a two-year study investigating frequency and timing of SABA use among 3,373 asthma patients. Objective data captured from Propeller’s passive sensors illustrates how granular data on medication use can illuminate new patterns of risk and impairment.

On Wednesday, Propeller presented data from an ongoing program with Dignity Health, where participants experienced significant reductions in acute asthma-related healthcare utilization, including ED visits, hospitalization and inpatient days.

Read more at PR Newswire

No Comments

Sorry, the comment form is closed at this time.